| Evolutionary genomics of epidemic visceral leishmaniasis in the Indian subcontinent H Imamura, T Downing, F Van den Broeck, MJ Sanders, S Rijal, S Sundar, ... Elife 5, e12613, 2016 | 162 | 2016 |
| Exploiting knowledge on Leishmania drug resistance to support the quest for new drugs A Hefnawy, M Berg, JC Dujardin, G De Muylder Trends in parasitology 33 (3), 162-174, 2017 | 129 | 2017 |
| Inhibitors of the purine salvage pathway: a valuable approach for antiprotozoal chemotherapy? M Berg, P Van der Veken, A Goeminne, A Haemers, K Augustyns Current medicinal chemistry 17 (23), 2456-2481, 2010 | 123 | 2010 |
| Evaluation of normalization methods to pave the way towards large-scale LC-MS-based metabolomics profiling experiments BA Ejigu, D Valkenborg, G Baggerman, M Vanaerschot, E Witters, ... Omics: a journal of integrative biology 17 (9), 473-485, 2013 | 122 | 2013 |
| Relapse after treatment with miltefosine for visceral leishmaniasis is associated with increased infectivity of the infecting Leishmania donovani strain K Rai, B Cuypers, NR Bhattarai, S Uranw, M Berg, B Ostyn, JC Dujardin, ... MBio 4 (5), 10.1128/mbio. 00611-13, 2013 | 83 | 2013 |
| Relapse after treatment with miltefosine for visceral leishmaniasis is associated with increased infectivity of the infecting Leishmania donovani strain K Rai, B Cuypers, NR Bhattarai, S Uranw, M Berg, B Ostyn, JC Dujardin, ... MBio 4 (5), 10.1128/mbio. 00611-13, 2013 | 83 | 2013 |
| Targeting ferroptosis protects against experimental (multi) organ dysfunction and death S Van Coillie, E Van San, I Goetschalckx, B Wiernicki, B Mukhopadhyay, ... Nature communications 13 (1), 1046, 2022 | 70 | 2022 |
| Arsenic in groundwater: poisoning and risk assessment MM Hassan Crc Press, 2018 | 70 | 2018 |
| LC-MS metabolomics from study design to data-analysis–using a versatile pathogen as a test case M Berg, M Vanaerschot, A Jankevics, B Cuypers, R Breitling, JC Dujardin Computational and structural biotechnology journal 4 (5), e201301002, 2013 | 64 | 2013 |
| Metabolic adaptations of Leishmania donovani in relation to differentiation, drug resistance, and drug pressure M Berg, M Vanaerschot, A Jankevics, B Cuypers, I Maes, S Mukherjee, ... Molecular microbiology 90 (2), 428-442, 2013 | 63 | 2013 |
| Experimental resistance to drug combinations in Leishmania donovani: metabolic and phenotypic adaptations M Berg, R García-Hernández, B Cuypers, M Vanaerschot, JI Manzano, ... Antimicrobial agents and chemotherapy 59 (4), 2242-2255, 2015 | 58 | 2015 |
| Effect of resolvins on sensitisation of TRPV1 and visceral hypersensitivity in IBS E Perna, J Aguilera-Lizarraga, MV Florens, P Jain, SA Theofanous, ... Gut 70 (7), 1275-1286, 2021 | 52 | 2021 |
| Evaluation of nucleoside hydrolase inhibitors for treatment of African trypanosomiasis M Berg, L Kohl, P Van der Veken, J Joossens, MI Al-Salabi, V Castagna, ... Antimicrobial Agents and Chemotherapy 54 (5), 1900-1908, 2010 | 51 | 2010 |
| (Post-) Genomic approaches to tackle drug resistance in Leishmania M Berg, AN Mannaert, M Vanaerschot, G Van der Auwera, JC Dujardin Parasitology 140 (12), 1492-1505, 2013 | 49 | 2013 |
| (Post-) Genomic approaches to tackle drug resistance in Leishmania M Berg, AN Mannaert, M Vanaerschot, G Van der Auwera, JC Dujardin Parasitology 140 (12), 1492-1505, 2013 | 49 | 2013 |
| Drug-resistant microorganisms with a higher fitness–can medicines boost pathogens? M Vanaerschot, S Decuypere, M Berg, S Roy, JC Dujardin Critical reviews in microbiology 39 (4), 384-394, 2013 | 46 | 2013 |
| Macromolecular biosynthetic parameters and metabolic profile in different life stages of Leishmania braziliensis: Amastigotes as a functionally less active stage M Jara, M Berg, G Caljon, G De Muylder, B Cuypers, D Castillo, I Maes, ... PloS one 12 (7), e0180532, 2017 | 40 | 2017 |
| N-Arylmethyl substituted iminoribitol derivatives as inhibitors of a purine specific nucleoside hydrolase A Goeminne, M Berg, M McNaughton, G Bal, G Surpateanu, ... Bioorganic & medicinal chemistry 16 (14), 6752-6763, 2008 | 40 | 2008 |
| α‐Ketoheterocycles as Inhibitors of Leishmania mexicana Cysteine Protease CPB K Steert, M Berg, JC Mottram, GD Westrop, GH Coombs, P Cos, L Maes, ... ChemMedChem 5 (10), 1734-1748, 2010 | 39 | 2010 |
| Integrated genomic and metabolomic profiling of ISC1, an emerging Leishmania donovani population in the Indian subcontinent B Cuypers, M Berg, H Imamura, F Dumetz, G De Muylder, ... Infection, Genetics and Evolution 62, 170-178, 2018 | 36 | 2018 |
